A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia

Clinical trial NCT05657574 · UNKNOWN

Trial details

NCT number: NCT05657574
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hypercholesterolemia

Start date: 2022-11-24
Primary completion: 2023-06-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.